Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 10th edition [PDF]
, 2022 Dear Colleagues!We are glad to present the 10th Edition (revised) of the Standards of Specialized Diabetes Care. These evidence-based guidelines were designed to standardize and facilitate diabetes care in all regions of the Russian Federation.The ...
Alexander Yu. Mayorov +35 more
core +1 more source
Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes [PDF]
, 2018 Significant number of patients with type 2 diabetes mellitus are obese. It is known that even glucose intolerance, as well as diabetes, can lead to vascular complications.
Milena Е. Telnova, Nina A. Petunina
core +2 more sources
Nephroprotective potential of glucagon-like peptide-1 receptor agonists [PDF]
, 2020 Patients with diabetes mellitus (DM), which is a key factor in the development of kidney diseases, are increasingly competing for limited healthcare resources.
Igor A. Sklyanik +2 more
core +1 more source
An economic value of the glycated hemoglobin test in diabetes mellitus type 2 diagnosis [PDF]
, 2019 BACKGROUND: Diagnostic of diabetes mellitus type 2 (DM2T) in time is very actual for treatment and prevention of potential complications of illness. Fasting blood glucose test (FBG) is a widely used method of primary DM2T diagnose.
Aleksey A. Kurylev +7 more
core +1 more source
Diabetes mellitus type 2 in adults [PDF]
, 2020 Public organization “Russian Association of Endocrinologists”.
Alexander S. Ametov +34 more
core +2 more sources
Mechanisms of cardiovascular protection of non-insulin antidiabetic medications [PDF]
, 2018 Patients with type 2 diabetes mellitus die most frequently from cardiovascular disease (CVD). Metabolic control is a cornerstone of both primary and secondary prevention of CVD: its important is two-fold since the normalization of HbA1c not only ...
Avogaro, Angelo
core +2 more sources
Heart failure in diabetes: From an increased risk to a treatment target [PDF]
, 2018 Heart failure (HF) is one of the most common comorbidities of type 2 diabetes mellitus (T2DM) and poor glycaemic control can worsen the HF outcomes and increase the risk of hospitalisations.
Eberhard Standl
core +1 more source
Кардиоваскулярные эффекты инкретиномиметиков и их терапевтический потенциал [PDF]
, 2017 Antidiabetic drugs with incretin activity in addition to pronounced hypoglycemic activity cause moderate reduction in blood pressure and fat mass as well as improve the lipid profile in patients with type 2 diabetes mellitus (T2DM).
Bakulin D.A. +3 more
core +2 more sources
The glucose-lowering therapy structure in special groups of type 2 diabetes mellitus patients based on data from the Moscow region register [PDF]
, 2019 BACKGROUND: Data of real clinical practice in diabetes mellitus (DM) register allow to evaluate features and trends in structure of glucose-lowering therapy (GLT).
Alexander V. Dreval +3 more
core +1 more source
Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs [PDF]
, 2018 In recent years, a large amount of data has been accumulated on the relationship between cognitive impairment, dementia and diabetes mellitus. This article presents an overview of modern literature, including the definition of cognitive functions, the ...
Ekaterina V. Rebrova +4 more
core +2 more sources